- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Buy the Dip
Global Pharmaceuticals & Biotech Buy the Dip
UPDATED Jul 03, 2022
Companies which may present a buying opportunity after a dip in share price.
270 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CURACuraleaf Holdings | CA$6.51 | -2.7% | -62.3% | CA$4.6b | CA$19.14 | PS2.8x | E74.2% | n/a | ||
| CNWco.don | €0.63 | 61.5% | -80.1% | €13.8m | €6.30 | PS2.1x | E74.2% | n/a | ||
| CHRSCoherus BioSciences | US$7.83 | 4.4% | -43.0% | US$606.2m | US$18.75 | PS2x | E71.5% | n/a | ||
| BHVNBiohaven Pharmaceutical Holding | US$145.31 | 1.1% | 45.6% | US$10.3b | US$158.35 | PS14x | E71.4% | n/a | ||
| MITRAMithra Pharmaceuticals | €6.95 | -17.1% | -69.1% | €347.2m | €25.43 | PS15.3x | E83.0% | 0% | ||
| CTICCTI BioPharma | US$6.08 | 4.5% | 133.8% | US$662.5m | US$9.58 | PS288.7x | E68.1% | n/a | ||
| FOLDAmicus Therapeutics | US$10.80 | -2.9% | 11.5% | US$3.0b | US$14.50 | PS9.5x | E71.2% | n/a | ||
| 300841Chengdu Kanghua Biological Products | CNÂ¥118.27 | 10.4% | -34.1% | CNÂ¥15.6b | CNÂ¥158.78 | PE18.4x | E27.8% | 0.8% | ||
| KZAKazia Therapeutics | AU$0.61 | -0.8% | -55.3% | AU$85.3m | AU$1.90 | PS5.6x | E59.5% | n/a | ||
| ADMAADMA Biologics | US$2.03 | 4.6% | 31.0% | US$398.6m | US$4.75 | PS4.2x | E66.9% | n/a | ||
| CDXCChromaDex | US$1.67 | -13.0% | -82.3% | US$114.4m | US$7.91 | PS1.6x | E68.6% | n/a | ||
| RCUSArcus Biosciences | US$26.50 | 3.7% | -3.0% | US$1.9b | US$57.20 | PE33.1x | E47.1% | n/a | ||
| ACADACADIA Pharmaceuticals | US$14.37 | -1.8% | -40.9% | US$2.3b | US$22.47 | PS4.7x | E78.6% | n/a | ||
| OPTNOptiNose | US$3.64 | 3.1% | 21.7% | US$301.0m | US$7.50 | PS3.9x | E68.4% | n/a | ||
| 524348Aarti Drugs | ₹397.60 | 1.2% | -45.4% | ₹36.8b | ₹477.00 | PE18x | E23.1% | 0.3% | ||
| CLBIOCorline Biomedical | kr9.78 | -3.6% | -15.3% | kr210.2m | kr30.00 | PS11.1x | E119.4% | n/a | ||
| HZNPHorizon Therapeutics | US$80.84 | -5.4% | -15.7% | US$18.6b | US$138.64 | PE21.6x | E24.3% | n/a | ||
| AVIRAtea Pharmaceuticals | US$7.30 | 2.5% | -68.6% | US$607.8m | US$10.25 | PE12.6x | E45.3% | n/a | ||
| ICPTIntercept Pharmaceuticals | US$14.13 | 4.8% | -29.3% | US$419.8m | US$26.93 | PS1.1x | E73.8% | n/a | ||
| IMMImmutep | AU$0.32 | 3.2% | -39.6% | AU$264.8m | AU$1.25 | PS73.2x | E62.9% | n/a | ||
| 300406Beijing Strong Biotechnologies | CNÂ¥18.07 | 3.0% | -12.3% | CNÂ¥10.2b | n/a | PE27.2x | E27.6% | 0.6% | ||
| 300601Shenzhen Kangtai Biological Products | CNÂ¥46.26 | 6.1% | -50.4% | CNÂ¥50.0b | CNÂ¥57.75 | PE34.3x | E27.6% | 1.6% | ||
| 1801Innovent Biologics | HK$38.00 | 7.0% | -57.3% | HK$51.2b | HK$48.79 | PS11.1x | E58.8% | n/a | ||
| BONEXBonesupport Holding | kr71.50 | 4.7% | -6.5% | kr4.6b | kr91.00 | PS19.7x | E111.6% | n/a |